Which of the following is an FDA-approved indication for Valsartan?

Valsartan, an angiotensin II receptor antagonist, is approved by the FDA for several cardiovascular conditions, with heart failure being one of the key indications. It works by blocking the effects of angiotensin II, a hormone that can increase blood pressure and cause fluid retention. In patients with heart failure, Valsartan helps to reduce symptoms and improve overall heart function by decreasing the workload on the heart and aiding in fluid management. This use is well-supported by clinical studies demonstrating its efficacy in managing heart failure, making it a cornerstone treatment in this area.

Diabetes, chronic pain, and asthma are not FDA-approved indications for Valsartan. While Valsartan may have benefits for diabetic patients concerning kidney protection, it is not specifically indicated for diabetes management. Chronic pain and asthma fall outside the scope of Valsartan's approved uses, as it is primarily focused on cardiovascular conditions. Thus, heart failure remains the definitive FDA-approved indication for Valsartan.